Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
HOYA&Min kone er Norsk&30 years experience with transatlantic tech transfer FRANTZMEDICAL
FRANTZMEDICAL • Who: • Frantz Medical Group / Ventures • What: • Biotech – devices and diagnostics • Why: • Growth areas with high return (despite high risk) • How: Source of new technology • Academic / clinical collaborations • Transatlantic access to I.P., markets & capital
FRANTZMEDICAL FRANTZ MEDICAL GROUP ORIGIN: 1976 U.S. CT Scanner > M.E., French pumps > U.S. EVOLVED: turn-key R&D manufacturing GROWTH: internal I.P. licensing JV (academic/clinical, industry)
FRANTZ MEDICAL VENTURES Unique VC model: In-house science operating company support “Co-venturer of Choice” to established VCs financial group FRANTZMEDICAL
FRANTZMEDICAL FRANTZ MEDICAL VENTURES PrognostiX
Areas of experience Devices, diagnostics - therapeutic enablers, crossovers – device/drugs Growth therapies Cardiovascular, orthopedics, metabolic, female medicine, …. Comfort with full spectrum of stages Start-up (FMG) >> middle level (FMV) FRANTZMEDICAL FOCUS
FRANTZMEDICAL FUNDAMENTAL CRITERIA Proprietary technology that serves an established or emerging need in a differentiated manner
Projected ROI Market Opportunity Market Size Strategic Partner Intellectual Property Time to Market Stage of Development Use of funds Negotiations/Deal Management Other Investors Scientific Support FMG Advocates Comments FRANTZMEDICAL Litmus Test criteria
FRANTZMEDICAL SOURCE In-house inventions Licenses Joint Ventures: • academic/clinical institutions • industrial partners
Academic/clinical institutions – long-term relationships Technion – FrantzTech Cleveland Clinic – Frantz BioMarkers, Merlot Orthopaedics) Access to wide range of technology, technologyplatforms, complementary resources: Clinical perspective Science Testing FRANTZMEDICAL MOST PROLIFIC
FRANTZMEDICAL FRANTZ BIOMARKERS
FRANTZMEDICAL TRANSATLANTIC COLLABORATION Experience France, Germany, Italy, U.K., Israel, Ukraine & NORWAY Common themes/issues: • Cultural > business practices, risk profile • I.P. – patenting, specific vs. platform
FRANTZMEDICAL NORWEGIAN PGS experience:applied American model to Norwegian technology (Ramform vessel design) • access to capital • motivational methods: stock options • = “Cowboys” Issues: conflicts over practices • GAAP • Foreign business practices, Sarbanes-Oxley VC approach in Norway….